Mary Ann Perle

969 citations
42 papers · 713 indexed · h-index 15
Topics
Prenatal Screening and Diagnostics (9 papers)Sarcoma Diagnosis and Treatment (8 papers)Cardiac tumors and thrombi (5 papers)

In The Last Decade

Mary Ann Perle

37 papers receiving 690 citations

Peers

Mary Ann Perle
Comparison fields: 5 of 57
  • Molecular Biology 298
  • Pulmonary and Respiratory Medicine 178
  • Oncology 163
  • Genetics 158
  • Cancer Research 120
Replace TS Ganesan with:
TS Ganesan United Kingdom
Regina Kunzmann Germany
Ross S. Berkowitz United States
Helen P. Kourea Greece
Guo‐Xia Tong United States
Kazunobu Sueyoshi Japan
Masamichi Bamba Japan
P Theunissen Netherlands
Eveline J. Kamping Netherlands
Yasumasa Monobe Japan
Mary Ann Perle relative to TS Ganesan United Kingdom TS Ganesan's profile →
Citations per field
00.5×
TS Ganesan · 1×
Citations per year

Countries citing papers authored by Mary Ann Perle

Since Specialization
Citations

This map shows the geographic impact of Mary Ann Perle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Ann Perle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Ann Perle more than expected).

Fields of papers citing papers by Mary Ann Perle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Ann Perle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Ann Perle. The network helps show where Mary Ann Perle may publish in the future.

Co-authorship network of co-authors of Mary Ann Perle

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Ann Perle. A scholar is included among the top collaborators of Mary Ann Perle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Ann Perle. Mary Ann Perle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 42
3 25
4 11
5 35
6 14
7 32
8 7
9 9
10 13
11 88
12 6
13 7
14 34
15 3
16 8
17 15
18 1
19 52
20 4

About Mary Ann Perle

Mary Ann Perle is a scholar working on Genetics, Pediatrics, Perinatology and Child Health and Hematology, having authored 42 papers that have together received 713 indexed citations. Recurring topics across this work include Prenatal Screening and Diagnostics (9 papers), Sarcoma Diagnosis and Treatment (8 papers) and Cardiac tumors and thrombi (5 papers). The work is most often cited by research in Cancer Research (120 citations), Obstetrics and Gynecology (55 citations) and Oncology (163 citations). Mary Ann Perle has collaborated with scholars based in United States, Spain and United Kingdom. Frequent co-authors include Helen Feiner, Hiroto Obata, Yan Chen, Giorgio Inghirami, Ruliang Xu, Daniel B. Rifkin, Branka Dabovic, Cristina Colarossi, J. Grifo and M.D. Werner. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and The Journal of Cell Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026